View of Rifaximin versus Placebo Preventing the Recurrence of Clinically Overt Hepatic Encephalopathy in Patients having Cirrhosis of Liver

Return to Article Details Rifaximin versus Placebo Preventing the Recurrence of Clinically Overt Hepatic Encephalopathy in Patients having Cirrhosis of Liver Download Download PDF